Prognostic serum biomarkers by COVID-19

• Conditions: J12.8; Other viral pneumonia

• Registration Number: DRKS00026655
• Lead Sponsor: niversity of Debrecen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-11-26
• Study Completion: 2022-06-21
• Results First Posted: 2023-06-29
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 67

Inclusion Criteria

Deep frozen serum samples of matched (age, sex, diabetes mellitus, nicotin consume and body weight) patients with SARS-Cov2 infection and control patients are going to be analised.

Exclusion Criteria

n.a.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Aim of this study to define novel prognositc biomarker by COVID-19

Secondary Outcome Measures

Name	Time	Method
Correlation of serum furin and CNP levels with the course of COVID-19